Dr. David P. Tingey

Dr. David P. Tingey

Dr. David P. Tingey BA, MD, FRCSC

Ivey Eye Institute
St. Joseph's Hospital
268 Grosvenor Street
London, Ontario N6A 4V2
Phone: 519.646.6100 ext. 58351
Fax: 519.646.6076

Specialty: Glaucoma
Clinical Focus: Glaucoma and Cataracts
Residency: Western University
Fellowship (Institution): Glaucoma,
Harvard University

Associate Professor, Western University


  1. Rizkalla K, Rodrigues S, Proulx A, Tingey DP, Heathcote JG. Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis. Can J Ophthalmol. October 2005, 40(5):585-92.
  2. Tingey D, Bernard LM, Grima DT, Miller B, Lam A: Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertension. Can J Ophthalmol. April 2005, 40(2):161-9.
  3. Houde M, Castilloux AM, Tingey D, Assalian A, LeLorier J. Prescription of topical antiglaucoma agents for patients with contraindications to beta blockers. Can J Ophthalmol. Oct 2003, 38(6): 469-75.
  4. Pope JE, Tingey DP, Arnold JM, Hong P, Ouimet JM, Krizova A. Are subjects satisfied with the informed consent process? A survey of research participants. J Rheumatol. April 2003, 30(4):815-24.
  5. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma. Einarson, T. R., Kulin, N. A., Tingey, D., and Iskedjian, M. Clin.Ther. 2000: 22; 1502-1515.
  6. Central corneal thickness in low-tension glaucoma. Emara, B. Y., Tingey, D. P., Probst, L. E., and Motolko, M. A. Can.J.Ophthalmol. 1999: 34; 319-324.
  7. Correlation of intraocular pressure and central corneal thickness in normal myopic eyes and after laser in situ keratomileusis. Emara, B., Probst, L. E., Tingey, D. P., Kennedy, D. W., Willms, L. J., and Machat, J. J.Cataract Refract.Surg. 1998: 24; 1320-1325.
  8. Stability of the antiproliferative effect of mitomycin-C after reconstitution. Woo, E., Tingey, D. P., Mackenzie, G., and Hooper, P. J.Glaucoma. 1997: 6; 33-36.
  9. Effects of cytoskeleton-reactive agents on aqueous outflow facility in a porcine ocular anterior segment preparation. Quinn, R. F. and Tingey, D. P. Can.J.Ophthalmol. 1995: 30; 4-10.
  10. Increased prevalence of occludable angles and angle-closure glaucoma in patients with pseudoexfoliation. Gross, F. J., Tingey, D., and Epstein, D. L. Am.J.Ophthalmol. 1994: 117; 333-336.
  11. The effect of intracameral ethacrynic acid on the intraocular pressure of living monkeys. Tingey, D. P., Ozment, R. R., Schroeder, A., and Epstein, D. L. Am.J.Ophthalmol. 1992: 113; 706-711.
  12. Effects of topical ethacrynic acid adducts on intraocular pressure in rabbits and monkeys. Tingey, D. P., Schroeder, A., Epstein, M. P., and Epstein, D. L. Arch.Ophthalmol. 1992: 110; 699-702.
  13. Ocular sarcoidosis presenting as a solitary choroidal mass. Tingey, D. P. and Gonder, J. R. Can.J.Ophthalmol. 1992: 27; 25-29.
  14. Corneal endothelial response to polymethylmethacrylate versus hydrogel lenses after phacoemulsification. Tingey, D. P., Nichols, B. D., Jung, S. E., and Randall, P. E. Can.J.Ophthalmol. 1991: 26; 3-6.